Upcon is a comprehensive concept built around a novel label technology known as photon upconversion. In this unique technology, upconverting nanoparticles (UCNPs) convert near-infrared (NIR) radiation to visible light via a unique process that enables the photoluminescence to be measured entirely free of autofluorescence and scattered excitation light. The UCNPs provide several advantages over traditional labels like conventional fluorophores or quantum dots. The Upcon- concept is intended for companies and research institutions working in the life science field. The concept includes both the upconverting nanoparticles and a first-of-its-kind microplate reader. The Upcon-particles are available either as ”ready-to-use” labels with streptavidin coupling, or with an amine reactive surface for use in your specific application.
Company Details
- Founded
- -
- Address
- Vajossuonkatu, 3 B,finland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.upcon.fi
- Keywords
- Ylöjärvi.
- HQ
- Turku, West and Inner Finland
Upcon - Upconverting Nanoparticle System Questions
Upcon - Upconverting Nanoparticle System's website is http://www.upcon.fi
Upcon - Upconverting Nanoparticle System's LinkedIn profile is https://fi.linkedin.com/company/upconvertingnanoparticles
Upcon - Upconverting Nanoparticle System's industry is
Biotechnology Research
Upcon - Upconverting Nanoparticle System's top competitors are
Jrs Pharma Oy,
Bioname Ltd,
Safeplast Oy,
Taklab Tampereen Asbesti- Ja Kuitulaboratorio Oy,
Ammox Oy,
Nanoparticle Therapy Institute,
Suomen Erityisjäte Oy,
Trafalgar Pharmacy,
C3c Engineering Oy (Finland),
Mevaset Oy.
Upcon - Upconverting Nanoparticle System's categories are Biotechnology Research
Upcon - Upconverting Nanoparticle System's founding year is 2014
